MINI FUTURE SHORT - MERCK & CO. | Market Closed - Boerse Frankfurt Warrants 01:20:31 14/05/2024 am IST | ||
| 4.73 EUR | +3.05% |
|
| Current month | +0.42% | ||
| 1 month | -6.48% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/24/13 | 4.76 | +3.70% | 0 |
| 10/24/10 | 4.59 | -0.22% | 0 |
| 09/24/09 | 4.6 | -1.29% | 0 |
| 08/24/08 | 4.66 | +0.87% | 0 |
| 07/24/07 | 4.62 | -5.13% | 0 |
Real-time Boerse Frankfurt Warrants
Last update May 14, 2024 at 01:20 am IST
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | MERCK & CO., INC. |
| Issuer | 
BNP Paribas
|
| WKN | PC4J2W |
| ISIN | DE000PC4J2W5 |
| Date issued | 05/02/2024 |
| Strike | 179.9 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 4.92 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 5.49 € |
|---|---|
| Lowest since issue | 4.33 € |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
129.3
USD
Average target price
141.6
USD
Spread / Average Target
+9.55%
- Stock Market
- Certificates
- Certificat